DIGESTIVE SYSTEM NEOPLASMS
Clinical trials for DIGESTIVE SYSTEM NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new DIGESTIVE SYSTEM NEOPLASMS trials appear
Sign up with your email to follow new studies for DIGESTIVE SYSTEM NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced colon cancer: experimental drug faces off against standard care
Disease control Recruiting nowThis study tests a new medicine (PF-08634404) combined with standard chemotherapy against an approved drug (bevacizumab) plus chemotherapy for people with colorectal cancer that has spread. About 800 adults who have not had prior treatment for metastatic disease will be randomly …
Matched conditions: DIGESTIVE SYSTEM NEOPLASMS
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 03:47 UTC
-
New heat probe zaps abdominal tumors without surgery
Disease control Recruiting nowThis study is testing a new way to treat solid tumors in the abdomen (like in the stomach, liver, or kidney) using a special ultrasound-guided needle that delivers heat to destroy the tumor. It is for 30 people who cannot have surgery or choose not to. The goal is to see if the p…
Matched conditions: DIGESTIVE SYSTEM NEOPLASMS
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
New combo attack shrinks untreatable liver tumors?
Disease control Recruiting nowThis study tests a powerful mix of treatments for people with advanced liver cancer that cannot be surgically removed. The approach combines tumor destruction (ablation), targeted therapy (lenvatinib), immunotherapy (tislelizumab), and a procedure that blocks the tumor's blood su…
Matched conditions: DIGESTIVE SYSTEM NEOPLASMS
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Quick quiz could catch muscle loss early in cancer patients
Knowledge-focused Recruiting nowThis study looks at how well a simple questionnaire (SARC-F) can identify gastrointestinal cancer patients who are at risk for sarcopenia—a condition where they lose muscle mass and strength. Sarcopenia can lead to more complications and worse outcomes, even in patients who seem …
Matched conditions: DIGESTIVE SYSTEM NEOPLASMS
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Knowledge-focused
Last updated May 26, 2026 03:50 UTC